Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results Signs Agreement to be Acquired by Catalent, Inc. CRINONE® Revenues Increased 12% and Juniper Pharma Services...
WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc. PR Newswire NEW YORK, July 5, 2018 NEW YORK, July 5, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty...
Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal? PR Newswire SAN DIEGO, July 3, 2018 SAN DIEGO, July 3, 2018...
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash PR Newswire BOSTON, July 3, 2018 BOSTON, July 3, 2018 /PRNewswire/ -- Juniper...
Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results Core Businesses Driving Strong Financial Performance CRINONE® Revenues Increased 30% and Juniper Pharma Services...
Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018 Conference Call Scheduled for 8:30 a.m. EST PR Newswire BOSTON, May 1, 2018 BOSTON, May 1, 2018 /PRNewswire/...
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience -Company Eligible to Receive Up to $43.75 Million in Milestones for Each IVR Candidate, Plus Royalties on...
Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors PR Newswire BOSTON, March 21, 2018 BOSTON, March 21, 2018 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), a...
Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results Full Year CRINONE® Revenues Increased 20% and Juniper Pharma Services (JPS) Revenues Increased 32...
Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018 Conference Call Scheduled for 8:30 a.m. EST PR Newswire BOSTON, March 2, 2018 BOSTON, March 2, 2018...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
